The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC
Status:
Recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the therapy effects and clinical safety of a
regulatory metabolic compound, coenzyme A (CoA) with a marketed drug, abiraterone, in Chinese
patients with castration-resistant prostate cancer (CRPC) .